The fluorenylmethoxycarbonyl (Fmoc)/tert-butyl (tBu) solid-phase method is categorically the present strategy of choice for the preparation of peptides for both research and industrial scales [1][2][3][4][5]. The main advantage of the Fmoc/tBu approach compared to the earlier tert-butyloxycarbonyl (Boc)/benzyl (Bzl) strategy is the conditions used to remove the temporal protecting group (Fmoc) and the permanent side-chain protecting groups as well as the separation/cleavage of the peptide from the resin. For the Boc/Bzl strategy, each removal of the temporal protecting group (Boc) requires treatment with trifluoroacetic acid (TFA) and the final stepthe cleavage of the peptide from the resinideally requires the concourse of HF. Although HF provokes very clean chemical reactions and is an optimal reagent to incorporate into a synthetic strategy, its use requires special Teflon reservoirs and may be forbidden in some geographical areas by local safety departments. These drawbacks are further magnified at an industrial scale. Conversely, the Fmoc/tBu strategy requires typically one or a maximum of two acid treatments.The absence of TFA for the release of the temporal protecting group in the Fmoc/ tBu strategy allows a gradual removal/cleavage of the remaining protecting groups. A final treatment of the peptide resin with a high concentration of TFA (approximately 90%) will render the totally free unprotected peptide. Alternatively, after choosing the proper resin, it is possible first to remove the protected peptide from the resin (1-5% TFA) and then to obtain the free peptide by treatment with a high concentration of TFA (Figure 10.1). This two-step cleavage/deprotection strategy allows modulation of the TFA treatment to minimize side-reactions and therefore increase the quality of the final product.Conversely, the protected peptide may be further elongated in solution by reaction with other protected peptides also prepared by solid-phase to accomplish the target molecule (convergent strategy, Figure 10.2) [6,7].Although there has been continuous development of new resins, linkers, protecting groups, and coupling reagents (see Chapter 12), the treatment of the protected peptide(-resin) with a high concentration of TFA is perhaps the key step for obtaining